Sage Therapeutics, Inc. (SAGE): Price and Financial Metrics
SAGE Price/Volume Stats
| Current price | $7.08 | 52-week high | $27.67 |
| Prev. close | $6.97 | 52-week low | $4.62 |
| Day low | $6.88 | Volume | 4,917,600 |
| Day high | $7.19 | Avg. volume | 3,616,727 |
| 50-day MA | $5.74 | Dividend yield | N/A |
| 200-day MA | $9.11 | Market Cap | 433.10M |
SAGE Stock Price Chart Interactive Chart >
Sage Therapeutics, Inc. (SAGE) Company Bio
Sage Therapeutics is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare central nervous system, or CNS, disorders. The company was founded in 2010 and is based in Cambridge, Massachusetts.
SAGE Price Returns
| 1-mo | 26.20% |
| 3-mo | -7.45% |
| 6-mo | -32.38% |
| 1-year | -73.05% |
| 3-year | -81.47% |
| 5-year | -89.95% |
| YTD | 30.39% |
| 2024 | -74.94% |
| 2023 | -43.18% |
| 2022 | -10.34% |
| 2021 | -50.83% |
| 2020 | 19.84% |
Continue Researching SAGE
Here are a few links from around the web to help you further your research on Sage Therapeutics Inc's stock as an investment opportunity:Sage Therapeutics Inc (SAGE) Stock Price | Nasdaq
Sage Therapeutics Inc (SAGE) Stock Quote, History and News - Yahoo Finance
Sage Therapeutics Inc (SAGE) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...